Skip to Main Content

Paper Details

Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma.
Blood Adv
5
2023
Author NameAffiliation
Borko JovanovicNorthwestern University Feinberg School of Medicine
Xinlei MiNorthwestern University Feinberg School of Medicine
  • 1 - 2

Datasets

Release 1.2